The role of eCyPA as an inflammatory biomarker for predicting 28-day mortality in ARDS patients
The findings suggest that eCyPA may serve as a potential biomarker for predicting 28-day mortality in patients with acute respiratory distress syndrome.
Authors
- Meijun Liu (ORCID: https://orcid.org/0000-0002-2951-7981)
- Ewan C. Goligher (ORCID: https://orcid.org/0000-0002-0990-6701)
- Jing Lv (ORCID: https://orcid.org/0000-0002-4007-5344)
- Juan Chen (ORCID: https://orcid.org/0000-0002-2057-3012)
- Wang Deng (ORCID: https://orcid.org/0000-0002-8109-5827)
- Xue Dai
Institutions
- University Health Network (CA)
- Dalian Medical University (CN)
- Toronto General Hospital (CA)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Public Health Medical Center (CN)
- Chongqing Municipal Health Commission (CN)
- Toronto General Hospital Research Institute
- Chongqing Medical University (CN)
Publication Details
- Journal
- Respiratory Research
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1186/s12931-025-03406-3
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chongqing Medical University
- Centre Scientifique et Technique du Bâtiment